"Participating in this clinical trial was a great option for me. I knew the extra time involved in participating in the trial would pay off, and it would also advance the future of medical science. My CAR-T experience gave me excellent results, and a return to normal life."

Doctors suspected that Zulema had lymphoma. But in July, she was officially diagnosed with intimal sarcoma, a rare type of malignant tumor, which mimics pulmonary thromboembolism. Her condition was impacting blood flowing from her face and brain to her heart.